Hiv Positive Persons Care
Mostrando 1-5 de 5 artigos, teses e dissertações.
-
1. Adhesion to anti-retroviral`s treatment by cartakers of soropositives children and adolescent of an unit of health of the State of Pará / Adesão ao tratamento anti-retroviral por cuidadores de crianças e adolescentes soropositivos de uma unidade de saúde do Estado do Pará
O tema da adesão ao tratamento tem recebido muita atenção dentro da Psicologia da Saúde nos últimos anos. Estudos nessa área revelam que os pacientes que não aderem ao tratamento podem não se beneficiar dos ganhos trazidos pela intervenção terapêutica. A literatura sobre adesão ao tratamento anti-retroviral revela que é o cuidador que geralmente
Publicado em: 2007
-
2. Clinical presentation and survival of smear-positive pulmonary tuberculosis patients of a University General Hospital in a developing country
From January 1995 to August 1997 we evaluated prospectively the clinical presentation, laboratory findings and short-term survival of smear-positive pulmonary tuberculosis (TB) patients who sought care at our hospital. After providing informed, written consent, the patients were interviewed and laboratory tests were performed. Information about survivorship
Memórias do Instituto Oswaldo Cruz. Publicado em: 2002-12
-
3. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.
OBJECTIVE: To employ the behavioral model of health services use in examining the extent to which predisposing, enabling, and need factors explain the treatment of the HIV-positive population in the United States with highly active antiretroviral therapy (HAART). DATA SOURCE: A national probability sample of 2,776 adults under treatment for human immunodefic
-
4. Acquired immunodeficiency syndrome and human immunodeficiency virus infection in Nevada.
We summarize information from three sets of epidemiologic data: the Nevada AIDS [acquired immunodeficiency syndrome] Surveillance System, which contains information about every case identified within the state boundaries through September 1989; the human immunodeficiency virus (HIV) seroprevalence reporting systems, which currently include data on all HIV-po
-
5. Salivary Secretory Leukocyte Protease Inhibitor and Oral Candidiasis in Human Immunodeficiency Virus Type 1-Infected Persons
Oropharyngeal candidiasis, typically caused by Candida albicans, is the most common oral disease associated with human immunodeficiency virus type 1 (HIV-1) infection. Secretory leukocyte protease inhibitor (SLPI), a 12-kDa antiprotease, suppresses the growth of C. albicans in vitro. To determine whether the mucosal protein plays a role in protecting oral ti
American Society for Microbiology.